Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Moscow ramping up COVID-19 vaccination

By Brian Buntz | March 1, 2021

Moscow

Photo by Elly Fairytale from Pexels

More than half a million people in Moscow have received the first dose of COVID-19 vaccine or about 4% of its population. Now, Russia is aiming to both ramp up domestic vaccinations and exports of its Sputnik V vaccine.  

Moscow has been one of the few cities that has had a surplus of COVID-19 vaccine. 

Now, some 12,000 to 20,000 residents sign up daily for the vaccines, according to the Department of Information Technologies of Moscow. 

The Russian capital has a population of 12.7 million.

The country’s two-dose Sputnik V vaccine has an efficacy of 91.6%, according to interim trial results. 

Moscow is administering the vaccines with a network of 100 clinics and 20 public places with mobile vaccinators. 

A growing number of categories of Moscow residents are eligible for the vaccine, which includes people over the age of 60, retirement-home residents and university students. 

Sputnik V

Sputnik V vaccine

Many large companies based in the city have requested on-site vaccination for their staff.  

Russia was one of the first countries to announce a widescale vaccination program. 

In January, Health Minister Mikhail Murashko said he expected at least 60% of the country’s population to be vaccinated by the middle of the year. 

As in many parts of the world, COVID-19 cases have fallen considerably in Russia in the first two months of 2021. 

Russia is also working to make its COVID-19 vaccine available to other countries. As of Feb. 19, some 50 countries had ordered 1.2 billion doses of the Sputnik V vaccine. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards